Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a pill ease tummy troubles for kids with IBS-C?

NCT ID NCT03596905

Completed Symptom relief Sponsor: Bausch Health Americas, Inc. Source: ClinicalTrials.gov ↗

First seen Jan 10, 2026 · Last updated Jun 23, 2026 · Updated 25 times

Summary

This study tested whether plecanatide (Trulance), a drug already approved for adults, can help children aged 6 to 17 with irritable bowel syndrome with constipation (IBS-C). Over 4 weeks, 218 participants took either plecanatide or a placebo daily and tracked their bowel movements and symptoms. The goal was to see if the drug increases spontaneous bowel movements and reduces abdominal pain safely.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME WITH CONSTIPATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Bausch Site 110

    Tampa, Florida, 33607, United States

  • Bausch Site 111

    Knoxville, Tennessee, 37922, United States

  • Bausch Site 112

    Lafayette, Louisiana, 70508, United States

  • Bausch Site 115

    Evansville, Indiana, 47715, United States

  • Bausch Site 120

    Newport News, Virginia, 23606, United States

  • Bausch Site 130

    Miami, Florida, 33134, United States

  • Bausch Site 132

    Atlanta, Georgia, 30342, United States

  • Bausch Site 135

    Doral, Florida, 33122, United States

  • Bausch Site 139

    Sioux City, Iowa, 51106, United States

  • Bausch Site 140

    San Antonio, Texas, 78215, United States

  • Bausch Site 142

    Los Angeles, California, 90036, United States

  • Bausch Site 143

    Ventura, California, 93003, United States

  • Bausch Site 145

    Akron, Ohio, 44308, United States

  • Bausch Site 146

    Bellevue, Washington, 98007, United States

  • Bausch Site 147

    Garden Grove, California, 92845, United States

  • Bausch Site 148

    Stockbridge, Georgia, 30281, United States

  • Bausch Site 150

    Miami, Florida, 33126, United States

  • Bausch Site 160

    Corona, California, 92879, United States

  • Bausch Site 165

    Miami, Florida, 33136, United States

  • Bausch Site 170

    Houston, Texas, 77087, United States

  • Bausch Site 172

    Covington, Louisiana, 70433, United States

  • Bausch Site 173

    Dallas, Texas, 75243, United States

  • Bausch Site 174

    Atlanta, Georgia, 30315, United States

  • Bausch Site 175

    Aurora, Colorado, 80012, United States

  • Bausch Site 176

    Scottsdale, Arizona, 85258, United States

  • Bausch Site 178

    Saraland, Alabama, 36571, United States

  • Bausch Site 180

    Crowley, Louisiana, 70526, United States

  • Bausch Site 190

    Hialeah, Florida, 33012, United States

  • Bausch Site 192

    Bowling Green, Kentucky, 42101, United States

  • Bausch Site 193

    Houston, Texas, 77030, United States

  • Bausch Site 194

    Cleveland, Ohio, 44106, United States

  • Bausch Site 195

    Austin, Texas, 78723, United States

  • Bausch Site 197

    Washington D.C., District of Columbia, 20016, United States

  • Bausch Site 220

    Omaha, Nebraska, 68134, United States

  • Bausch Site 225

    Cedar Park, Texas, 78613, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

plecanatide (Trulance)

What this could lead to

If it works, this could provide a new treatment option for children with IBS-C to improve bowel movements and reduce abdominal pain.

What could go wrong

This is a Phase 2 trial with only 218 participants, so results may not confirm effectiveness or safety. The drug may not work better than placebo, and side effects are possible.

Conditions

The condition(s) this trial relates to.

irritable bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IRRITABLE BOWEL SYNDROME WITH CONSTIPATION